BioStock: WntResearch receives attention for results with Foxy-5 in AML

In addition to last year’s new discoveries regarding Foxy-5, WntResearch continues to investigate the candidate’s potential outside colon cancer. Promising preclinical results with Foxy-5 in acute myeloid leukemia have now been published in the Journal of Cell Communication and Signaling. BioStock contacted CEO Pernilla Sandwall for an update from the project.

Read the full article at biostock.se:

https://www.biostock.se/en/2023/06/wntresearch-receives-attention-for-results-with-foxy-5-in-aml/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se